BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

695 related articles for article (PubMed ID: 16741310)

  • 1. Impact of animal handling on the results of 18F-FDG PET studies in mice.
    Fueger BJ; Czernin J; Hildebrandt I; Tran C; Halpern BS; Stout D; Phelps ME; Weber WA
    J Nucl Med; 2006 Jun; 47(6):999-1006. PubMed ID: 16741310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retro-orbital injection is an effective route for radiopharmaceutical administration in mice during small-animal PET studies.
    Nanni C; Pettinato C; Ambrosini V; Spinelli A; Trespidi S; Rubello D; Al-Nahhas A; Franchi R; Alavi A; Fanti S
    Nucl Med Commun; 2007 Jul; 28(7):547-53. PubMed ID: 17538396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
    Metser U; Even-Sapir E
    Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and patterns of physiologic muscle uptake detected with whole-body 18F-FDG PET.
    Jackson RS; Schlarman TC; Hubble WL; Osman MM
    J Nucl Med Technol; 2006 Mar; 34(1):29-33. PubMed ID: 16517966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of anesthetic agents and fasting duration on 18F-FDG biodistribution and insulin levels in tumor-bearing mice.
    Lee KH; Ko BH; Paik JY; Jung KH; Choe YS; Choi Y; Kim BT
    J Nucl Med; 2005 Sep; 46(9):1531-6. PubMed ID: 16157537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absolute quantification of regional cerebral glucose utilization in mice by 18F-FDG small animal PET scanning and 2-14C-DG autoradiography.
    Toyama H; Ichise M; Liow JS; Modell KJ; Vines DC; Esaki T; Cook M; Seidel J; Sokoloff L; Green MV; Innis RB
    J Nucl Med; 2004 Aug; 45(8):1398-405. PubMed ID: 15299067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation.
    Wykrzykowska J; Lehman S; Williams G; Parker JA; Palmer MR; Varkey S; Kolodny G; Laham R
    J Nucl Med; 2009 Apr; 50(4):563-8. PubMed ID: 19289431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of corticosteroids on 18F-FDG uptake in tumor lesions after chemotherapy.
    Brepoels L; Stroobants S; Vandenberghe P; Spaepen K; Dupont P; Nuyts J; Bormans G; Mortelmans L; Verhoef G; De Wolf-Peeters C
    J Nucl Med; 2007 Mar; 48(3):390-7. PubMed ID: 17332616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
    Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M
    J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma.
    Park JW; Kim JH; Kim SK; Kang KW; Park KW; Choi JI; Lee WJ; Kim CM; Nam BH
    J Nucl Med; 2008 Dec; 49(12):1912-21. PubMed ID: 18997056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of organ-specific glucose metabolism by ¹⁸F-FDG in insulin receptor substrate-1 (IRS-1) knockout mice as a model of insulin resistance.
    Cheng C; Nakamura A; Minamimoto R; Shinoda K; Tateishi U; Goto A; Kadowaki T; Terauchi Y; Inoue T
    Ann Nucl Med; 2011 Dec; 25(10):755-61. PubMed ID: 21818569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory cytokines and hypoxia contribute to 18F-FDG uptake by cells involved in pannus formation in rheumatoid arthritis.
    Matsui T; Nakata N; Nagai S; Nakatani A; Takahashi M; Momose T; Ohtomo K; Koyasu S
    J Nucl Med; 2009 Jun; 50(6):920-6. PubMed ID: 19443596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT.
    Bogsrud TV; Karantanis D; Nathan MA; Mullan BP; Wiseman GA; Collins DA; Kasperbauer JL; Strome SE; Reading CC; Hay ID; Lowe VJ
    Nucl Med Commun; 2007 May; 28(5):373-81. PubMed ID: 17414887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of age-related changes in structure and function of skin, adipose tissue, and skeletal muscle with computed tomography, magnetic resonance imaging, and positron emission tomography.
    Wehrli NE; Bural G; Houseni M; Alkhawaldeh K; Alavi A; Torigian DA
    Semin Nucl Med; 2007 May; 37(3):195-205. PubMed ID: 17418152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-[18F]-2-deoxy-D-glucose (FDG) uptake in human tumor cells is related to the expression of GLUT-1 and hexokinase II.
    Ong LC; Jin Y; Song IC; Yu S; Zhang K; Chow PK
    Acta Radiol; 2008 Dec; 49(10):1145-53. PubMed ID: 18979289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation methods prior to PET/CT scanning that decrease uptake of 18F-FDG by myocardium, brown adipose tissue, and skeletal muscle.
    Shao D; Tian XW; Gao Q; Liang CH; Wang SX
    Acta Radiol; 2017 Jan; 58(1):10-18. PubMed ID: 26936898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of anesthesia effects on [18F]FDG uptake in mouse brain and heart using small animal PET.
    Toyama H; Ichise M; Liow JS; Vines DC; Seneca NM; Modell KJ; Seidel J; Green MV; Innis RB
    Nucl Med Biol; 2004 Feb; 31(2):251-6. PubMed ID: 15013491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodal assessment of in vivo metabolism with hyperpolarized [1-13C]MR spectroscopy and 18F-FDG PET imaging in hepatocellular carcinoma tumor-bearing rats.
    Menzel MI; Farrell EV; Janich MA; Khegai O; Wiesinger F; Nekolla S; Otto AM; Haase A; Schulte RF; Schwaiger M
    J Nucl Med; 2013 Jul; 54(7):1113-9. PubMed ID: 23596002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-FDG small-animal PET/CT differentiates trastuzumab-responsive from unresponsive human breast cancer xenografts in athymic mice.
    McLarty K; Fasih A; Scollard DA; Done SJ; Vines DC; Green DE; Costantini DL; Reilly RM
    J Nucl Med; 2009 Nov; 50(11):1848-56. PubMed ID: 19837760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
    Inglese E; Leva L; Matheoud R; Sacchetti G; Secco C; Gandolfo P; Brambilla M; Sambuceti G
    J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.